Background: Telmisartan, used for the treatment of hypertension, has been shown to function as a partial
. 최근에는 간단하면 서도 비침습적인 방법인 brachial-ankle PWV (baPWV) 측정 을 이용하여 동맥의 경직 정도를 평가 할 수 있게 되었다 11) . 6.7 ± 0.7 6.9 ± 0.8 0.329
이와 관련된 최근의 연구들을 보면 고혈압환자에게
2.5 ± 0.7 2.6 ± 0.7 0.711 Adiponectin (μg/mL) 8.2 ± 7.9 6.8 ± 3.3 0.559 Interleukin-6 (pg/mL) 3.1 ± 3.2 3.7 ± 3.6 0.600 baPWV (cm/sec) 1934.8 ± 366.7 1907.3 ± 377.2 0.123 Antidiabetic agent (%) Sulfonylurea 11 (68.8%) 13 (81.3%) 0.564 Biguanide 7 (43.8%) 6 (37.5%) 0.780 α-glucosidase inhibitor 1 (6.3%) 1 (6.3%) 1.000 Thiazolidinedione 4 (25%) 4 (25%) 1.000 BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMAIR ,homeostasis model of assessment insulin resistance; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol. * P-values were obtained using the Student's t-test. 6.7 ± 0.7 7.0 ± 0.9 6.9 ± 0.8 7.0 ± 0.8 0.852 HOMA index 3.7 ± 2.1 3.7 ± 0.8 3.7 ± 2.8 3.8 ± 1.2 0.638 Total cholesterol (mmol/L) 4.6 ± 0.8 4.6 ± 0.8 4.7 ± 0.9 4.5 ± 0.8 0.231 Triglyceride (mmol/L) 2.0 ± 1.6 1.9 ± 0.7 1.9 ± 0.6
2.5 ± 0.7 2.6 ± 0.6 2.6 ± 0.7 2.4 ± 0.6 0.218 Interleukin-6 (pg/mL) 3.1 ± 3.2 3.0 ± 3.8 3.7 ± 3.6 3.0 ± 3.4 0.392 BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMAIR ,homeostasis model of assessment insulin resistance; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol. * Significant changes from baseline to week 12 are indicated by a P < 0.05. † § P-values were obtained using the Student's t-test based on changes between baseline and week 12 in each group. 3:176-80, 2002 
